Percy Ivy
- Molecular Biology top 5%
- Oncology top 2%
- Pulmonary and Respiratory Medicine top 2%
- Cancer Research top 2%
- Genetics top 1%
- Co-authors
- Tracy T. BatchelorRakesh K. JainA. Gregory SorensenEdward A. SausvilleJoseph E. TomaszewskiPatrick Y. WenMarek AncukiewiczDan G. Duda
- Topics
- Cancer Treatment and Pharmacology (26 papers)Colorectal Cancer Treatments and Studies (21 papers)Cancer therapeutics and mechanisms (17 papers)
- Cited by
- GeneticsCancer ResearchOncology
- Partner nations
- United StatesCanadaNew Zealand
In The Last Decade
Percy Ivy
116 papers receiving 4.4k citations
Peers
Comparison fields: 5 of 129
- Molecular Biology 1.9k
- Oncology 1.5k
- Pulmonary and Respiratory Medicine 883
- Cancer Research 869
- Genetics 731
Countries citing papers authored by Percy Ivy
This map shows the geographic impact of Percy Ivy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Percy Ivy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Percy Ivy more than expected).
Fields of papers citing papers by Percy Ivy
This network shows the impact of papers produced by Percy Ivy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Percy Ivy. The network helps show where Percy Ivy may publish in the future.
Co-authorship network of co-authors of Percy Ivy
This figure shows the co-authorship network connecting the top 25 collaborators of Percy Ivy. A scholar is included among the top collaborators of Percy Ivy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Percy Ivy. Percy Ivy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Expanded access trial of tocilizumab in COVID19+hospitalized cancer patients | 1 |
| 2 | 5 | |
| 3 | 33 | |
| 4 | 43 | |
| 5 | 5 | |
| 6 | 177 | |
| 7 | 176 | |
| 8 | 10 | |
| 9 | 241 | |
| 10 | 406 | |
| 11 | 17 | |
| 12 | 14 | |
| 13 | 16 | |
| 14 | 86 | |
| 15 | Phase II study of Cediranib (RECENTIN™, AZD2171) in recurrent epithelial ovarian cancer | 1 |
| 16 | A Phase 2 study of AZD2171 in recurrent or persistent ovarian, peritoneal or fallopian tube cancer. A study of the PMH, Chicago, and California Phase II Consortia | 1 |
| 17 | 19 | |
| 18 | 55 | |
| 19 | 9 | |
| 20 | 15 |
About Percy Ivy
Percy Ivy is a scholar working on Oncology, Cancer Research and Genetics, having authored 120 papers that have together received 4.5k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (26 papers), Colorectal Cancer Treatments and Studies (21 papers) and Cancer therapeutics and mechanisms (17 papers). The work is most often cited by research in Genetics (731 citations), Cancer Research (869 citations) and Oncology (1.5k citations). Percy Ivy has collaborated with scholars based in United States, Canada and New Zealand. Frequent co-authors include Tracy T. Batchelor, Rakesh K. Jain, A. Gregory Sorensen, Edward A. Sausville, Joseph E. Tomaszewski, Patrick Y. Wen, Marek Ancukiewicz, Dan G. Duda, Elizabeth R. Gerstner and Jay S. Loeffler. Their work appears in journals such as Nature Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.